One year after its launch, IBSA celebrates the successes achieved with Vitamin D3 IBSA. It is a product that stood out for its unique characteristics, and which has brought innovation to a constantly developing but low-innovation market, that being the vitamin D supplements one.
IBSA Vitamin D3 is the first vitamin D-based supplement with IBSA FilmTec® patented technology, an orodispersible film (ODF) consisting of an ultra-thin strip of polymeric material (50-150 microns thick), comparable to the size of a postage stamp. Once placed in the oral cavity, in contact with saliva it dissolves in a few tens of seconds, providing a rapid bioavailability of the active ingredient.
Thanks to the immediate assumption of the vitamin D, IBSA has been able to respond to the growing need for supplementation after the recent pandemic. People were forced to stay indoors and there was a consequent reduction of exposure to sunlight, necessary to the natural synthesis of vitamin D. The latter is essential for the body, as it contributes to the normal functioning of the immune system and to the maintenance of healthy bones. Therefore, it is important for all age groups to maintain adequate doses of vitamin D.
IBSA Vitamin D3 with FilmTec® patented technology is available in two dosages (1000 IU and 2000 IU) and can be administrated daily. It is also easy to take, as it directly dissolves in the mouth without the need for water. All in all, the supplement is an excellent solution even for those who have difficulty swallowing or drinking the typical dissolved oral forms. In addition, IBSA Vitamin D3 offers further advantages: it is gluten-free, GMO-free and lactose-free, contains less than 1 kilocalorie and has a natural orange flavor, which makes it very pleasant to take.
IBSA Vitamin D3 is a "Made in Italy" product, developed by the Italian Research & Development team.
IBSA Vitamin D3 has received two important awards in 2021: Life Science Excellence Awards 2021 and the Product of the Year award 2021. The former awarded IBSA's ability to activate a multichannel communication plan, highly focused on television media; the latter instead, confirmed consumers' interest towards this user–friendly product, which is capable to respond to the most various care needs.
The orodispersible films are receiving increasing attention from consumers, as they represent a new frontier in the field of oral administration of drugs, nutraceuticals and food supplements.
This is why IBSA has the goal to develop a new line of food supplements with the orodispersible film, based on the innovative IBSA FilmTec® technology.